IIM
RCEL icon

INTECH Investment Management’s Avita Medical RCEL Stock Holding History

INTECH Investment Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,432
Closed -$63.5K – 2431
2025
Q3 		$63.5K Buy
12,432
+1,100
+10% +$5.74K ﹤0.01% 2349
2025
Q2 		$59.9K Sell
11,332
-6,190
-35% -$45K ﹤0.01% 2399
2025
Q1 		$143K Buy
17,522
+6,961
+66% +$65K ﹤0.01% 2213
2024
Q4 		$135K Buy
+10,561
New +$125K ﹤0.01% 2143

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

INTECH Investment Management's RCEL Position: Q4 2025 in Review

INTECH Investment Management sold out of Avita Medical (RCEL) in Q4 2025, closing a stake of 12,432 shares — an estimated $63.5K sold.

INTECH Investment Management first reported a position in RCEL in Q4 2024 and held it in 4 quarters. The position peaked at $143K in Q1 2025. 67 funds tracked by Wall St. Rank hold RCEL as of Q4 2025.

  • INTECH Investment Management reported no remaining Avita Medical position as of Q4 2025 after selling out during the quarter.
  • INTECH Investment Management sold 12,432 Avita Medical shares in Q4 2025, an estimated $63.5K.
  • INTECH Investment Management first reported a position in Avita Medical in Q4 2024 and held it in 4 quarters.
  • INTECH Investment Management's Avita Medical position peaked at $143K in Q1 2025.
  • 67 funds tracked by Wall St. Rank held Avita Medical as of Q4 2025.

Based on INTECH Investment Management's 13F filing for Q4 2025, filed 10 Feb 2026.